Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Smoking Cessation 2Vaping 1Uterine Cervical Dysplasia 1Tobacco Use Disorder 1Tobacco Smoking 1Substance-Related Disorders 1Lung Neoplasms 1

Interventions

Specimen Handling 51Carboplatin 51pembrolizumab 46Magnetic Resonance Spectroscopy 43Pemetrexed 40Cisplatin 35durvalumab 24Paclitaxel 24osimertinib 20Nivolumab 19Gemcitabine 19Radiosurgery 17Docetaxel 17atezolizumab 14Taxes 12Radiotherapy 12Immunoglobulin G 12Disulfides 12130-nm albumin-bound paclitaxel 12Radiation 11Etoposide 11Educational Status 11Biopsy 11Drug Therapy 10Blood Specimen Collection 10Platinum 9Early Intervention, Educational 9Cetuximab 9Methods 8Bevacizumab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Neoplasms × Nicotine Replacement Therapy × 90 days × Clear all
NCT05144542 2026-04-15

Risk and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer

M.D. Anderson Cancer Center

Phase NA Active not recruiting
140 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡